These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16173956

  • 1. Optimizing therapy for myeloid disorders of Down syndrome.
    Webb DK.
    Br J Haematol; 2005 Oct; 131(1):3-7. PubMed ID: 16173956
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C, Creutzig U, Reinhardt D.
    Klin Padiatr; 2005 Oct; 217(3):126-34. PubMed ID: 15858703
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.
    Gamis AS.
    Pediatr Blood Cancer; 2005 Jan; 44(1):13-20. PubMed ID: 15534881
    [Abstract] [Full Text] [Related]

  • 8. Down syndrome, drug metabolism and chromosome 21.
    Taub JW, Ge Y.
    Pediatr Blood Cancer; 2005 Jan; 44(1):33-9. PubMed ID: 15390307
    [Abstract] [Full Text] [Related]

  • 9. GATA1 mutations in acute leukemia in children with Down syndrome.
    Magalhães IQ, Splendore A, Emerenciano M, Figueiredo A, Ferrari I, Pombo-de-Oliveira MS.
    Cancer Genet Cytogenet; 2006 Apr 15; 166(2):112-6. PubMed ID: 16631466
    [Abstract] [Full Text] [Related]

  • 10. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
    Kudo K, Kojima S, Tabuchi K, Yabe H, Tawa A, Imaizumi M, Hanada R, Hamamoto K, Kobayashi R, Morimoto A, Nakayama H, Tsuchida M, Horibe K, Kigasawa H, Tsukimoto I, Japanese Childhood AML Cooperative Study Group.
    J Clin Oncol; 2007 Dec 01; 25(34):5442-7. PubMed ID: 18048827
    [Abstract] [Full Text] [Related]

  • 11. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann J, Niemeyer CM, Reiter A, Ritter J, Dworzak M, Stary J, Reinhardt D.
    J Clin Oncol; 2006 Sep 20; 24(27):4499-506. PubMed ID: 16983120
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy for myeloid malignancy in children with Fanconi anemia.
    Mehta PA, Ileri T, Harris RE, Williams DA, Mo J, Smolarek T, Auerbach AD, Kelly P, Davies SM.
    Pediatr Blood Cancer; 2007 Jun 15; 48(7):668-72. PubMed ID: 16609946
    [Abstract] [Full Text] [Related]

  • 13. Myeloid leukaemia in children with Down syndrome: report of the registry-based French experience between 1990 and 2003.
    Tandonnet J, Clavel J, Baruchel A, Nacka F, Pérel Y.
    Pediatr Blood Cancer; 2010 Jul 01; 54(7):927-33. PubMed ID: 20405513
    [Abstract] [Full Text] [Related]

  • 14. Acute leukemias in children with Down syndrome.
    Zwaan MC, Reinhardt D, Hitzler J, Vyas P.
    Pediatr Clin North Am; 2008 Feb 01; 55(1):53-70, x. PubMed ID: 18242315
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.
    Rao A, Hills RK, Stiller C, Gibson BE, de Graaf SS, Hann IM, O'Marcaigh A, Wheatley K, Webb DK.
    Br J Haematol; 2006 Mar 01; 132(5):576-83. PubMed ID: 16445830
    [Abstract] [Full Text] [Related]

  • 18. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
    Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, Gold S, Sanders J, Neudorf S, Smith FO, Woods WG.
    Blood; 1998 Jan 15; 91(2):608-15. PubMed ID: 9427716
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.